MedPath

Efficacy Study of EVT 201 to Treat Insomnia

Phase 2
Completed
Conditions
Sleep Initiation and Maintenance Disorders
Registration Number
NCT00380003
Lead Sponsor
Evotec Neurosciences GmbH
Brief Summary

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • must have a diagnosis of primary insomnia
  • over the last three months, must have a normal bedtime of between 9 pm and 1 am and a time in bed of at least 7 hours
  • must be able to attend the Sleep Center for two consecutive nights on four occasions over a two month period
  • must be willing and able to complete a sleep diary and questionnaires
Exclusion Criteria
  • must not have a clinically significant or unstable medical condition that may interfere with sleep
  • must not have a major psychiatric disorder (other than insomnia) such as depression, schizophrenia, bipolar disorder
  • must not be currently using any medication know to affect sleep e.g. hypnotics, anxiolytics,antidepressants, antihistamines, anticonvulsants
  • must not intentionally nap 3 (or more) times per week
  • must not smoke more than 10 cigarettes per day and /or be able not to smoke without distress or discomfort for the duration of visits to the sleep laboratory ( i.e. approximately 12 hours)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Total Sleep Time
Wake after sleep onset
Secondary Outcome Measures
NameTimeMethod
Residual sedation measures
REM latency
Patient reported sleep variables
Latency to persistent sleep
Total wake time
Minutes of stages 1-4 and REM sleep
Number of awakenings
Safety assessments including adverse events, ECgs, vital signs and routine laboratory assessments.

Trial Locations

Locations (5)

The Sleep Disorders Center of Georgia, Peachtree Dunwoody Medical Center,5505 Peachtree Dunwoody Road, Suite 548

🇺🇸

Atlanta, Georgia, United States

Vince and Associates Clinical Research

🇺🇸

Overland Park, Kansas, United States

Tri-State Sleep Disorders Center

🇺🇸

Cincinnati, Ohio, United States

St. Luke's Hospital

🇺🇸

Chesterfield (St Louis), Missouri, United States

St Petersburg Sleep Disorders Center

🇺🇸

St Petersburg, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath